OPKO Health, Inc. Payments to Acquire Equity Method Investments
OPKO Health, Inc. (OPK) reported Payments to Acquire Equity Method Investments of $13.34 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2013-08-09
- OPKO Health, Inc. payments to acquire equity method investments for the quarter ending 2013-06-30 was $10.84M.
- OPKO Health, Inc. payments to acquire equity method investments for the quarter ending 2013-03-31 was $2.50M, a 7.41% decline year-over-year.
- OPKO Health, Inc. payments to acquire equity method investments for the quarter ending 2012-12-31 was $696.00K.
- OPKO Health, Inc. payments to acquire equity method investments for the quarter ending 2012-09-30 was $0.00.
- OPKO Health, Inc. payments to acquire equity method investments for fiscal 2012 was $3.40M, a 68.70% increase from fiscal 2011.
- OPKO Health, Inc. payments to acquire equity method investments for fiscal 2011 was $2.01M, a 209.69% increase from fiscal 2010.
- OPKO Health, Inc. payments to acquire equity method investments for fiscal 2010 was $650.00K, a 86.46% decline from fiscal 2009.
- OPKO Health, Inc. payments to acquire equity method investments for fiscal 2009 was $4.80M.
| Period end | Payments to Acquire Equity Method Investments 1 month | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|---|---|
| 2013-06-30 | $10.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $13.34M 10-Q · filed 2013-08-09 | $14.04M derived: sum of 3 quarters · filed 2013-08-09 | $14.04M derived: sum of 4 quarters · filed 2013-08-09 | |
| 2013-03-31 | $2.50M 10-Q · filed 2013-05-10 | $3.20M derived: sum of 2 quarters · filed 2013-05-10 | $3.20M derived: sum of 3 quarters · filed 2013-05-10 | $3.20M derived: sum of 4 quarters · filed 2013-08-09 | |
| 2012-12-31 | $696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $696.00K derived: sum of 2 quarters · filed 2013-03-18 | $696.00K derived: sum of 3 quarters · filed 2013-08-09 | $3.40M 10-K · filed 2013-03-18 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2013-08-09 | $2.70M 10-Q · filed 2012-11-09 | $2.70M derived: sum of 4 quarters · filed 2013-08-09 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.70M 10-Q · filed 2013-08-09 | $2.70M derived: sum of 3 quarters · filed 2013-08-09 | ||
| 2012-03-31 | $2.70M 10-Q · filed 2013-05-10 | $2.70M derived: sum of 2 quarters · filed 2013-05-10 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.01M 10-K · filed 2013-03-18 | |||
| 2011-09-30 | $2.01M 10-Q · filed 2012-11-09 | ||||
| 2011-08-31 | $2.00M 10-Q · filed 2013-08-09 | ||||
| 2010-12-31 | $650.00K 10-K · filed 2013-03-18 | ||||
| 2009-12-31 | $4.80M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |